These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2437972)

  • 1. Anticoagulant hydrogels derived from crosslinked dextran. Part II: Mechanism of thrombin inactivation.
    Aubert N; Mauzac M; Gulino D; Jozefonvicz J
    Biomaterials; 1987 Mar; 8(2):100-4. PubMed ID: 2437972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulant activity of dextran derivatives. Part II: Mechanism of thrombin inactivation.
    Fischer AM; Mauzac M; Tapon-Bretaudiere J; Jozefonvicz J
    Biomaterials; 1985 May; 6(3):198-202. PubMed ID: 2408688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulant hydrogels derived from crosslinked dextran. Part I: Synthesis, characterization and antithrombic activity.
    Aubert N; Mauzac M; Jozefonvicz J
    Biomaterials; 1987 Jan; 8(1):24-9. PubMed ID: 2435328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulant activity of dextran derivatives.
    de Raucourt E; Mauray S; Chaubet F; Maiga-Revel O; Jozefowicz M; Fischer AM
    J Biomed Mater Res; 1998 Jul; 41(1):49-57. PubMed ID: 9641623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of thrombin inactivation by immobilized heparin.
    Byun Y; Jacobs HA; Kim SW
    J Biomed Mater Res; 1996 Apr; 30(4):423-7. PubMed ID: 8847350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permeability of a heparin-polyvinyl alcohol hydrogel to thrombin and antithrombin III.
    Smith BA; Sefton MV
    J Biomed Mater Res; 1988 Aug; 22(8):673-85. PubMed ID: 3215905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of NaC1 on inactivation of bovine thrombin by antithrombin III in the presence of low affinity-heparin or dextran sulfate.
    Oshima G; Nagasawa K
    Thromb Res; 1986 Feb; 41(3):361-72. PubMed ID: 2422780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity toward thrombin-antithrombin of heparin immobilized on two hydrogels.
    Tay SW; Merrill EW; Salzman EW; Lindon J
    Biomaterials; 1989 Jan; 10(1):11-5. PubMed ID: 2713428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-like functionalized polymer surfaces: discrimination between catalytic and adsorption processes during the course of thrombin inhibition.
    Charef S; Tapon-Bretaudière J; Fischer AM; Pflüger F; Jozefowicz M; Labarre D
    Biomaterials; 1996 May; 17(9):903-12. PubMed ID: 8718936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative anticoagulant activity and influence on thrombin generation of dextran derivatives and of a fucoidan fraction.
    Mauray S; De Raucourt E; Chaubet F; Maïga-Revel O; Sternberg C; Fischer AM
    J Biomater Sci Polym Ed; 1998; 9(4):373-87. PubMed ID: 9586785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-like anticoagulant activity of sulphonated poly(ethylene oxide) and sulphonated poly(ethylene oxide)-grafted polyurethane.
    Han DK; Lee NY; Park KD; Kim YH; Cho HI; Min BG
    Biomaterials; 1995 Apr; 16(6):467-71. PubMed ID: 7654873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dextran sulphates on thrombin activity.
    Suzuki K; Hashimoto S
    J Clin Pathol; 1979 May; 32(5):439-44. PubMed ID: 469001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of thrombin inhibition by heparin cofactor II in the presence of dermatan sulphates, native or oversulphated, and a heparin-like dextran derivative.
    Maaroufi RM; Jozefowicz M; Tapon-Bretaudière J; Jozefonvicz J; Fischer AM
    Biomaterials; 1997 Feb; 18(4):359-66. PubMed ID: 9068899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity of purified thrombin or antithrombin III for two insoluble anticoagulant polystyrene derivatives: I. In vitro adsorption studies.
    Fougnot C; Jozefowicz M; Rosenberg RD
    Biomaterials; 1983 Oct; 4(4):294-8. PubMed ID: 6640057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A kinetic study on the effects of anticoagulants on the interaction of fibrinogen and thrombin.
    Nakanishi E; Sato H; Nakajima A
    J Biomed Mater Res; 1987 Feb; 21(2):187-200. PubMed ID: 2434508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic analysis of various heparin fractions and heparin substitutes in the thrombin inhibition reaction.
    Pletcher CH; Cunningham M; Nelsestuen GL
    Biochim Biophys Acta; 1985 Jan; 838(1):106-13. PubMed ID: 2578296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-like tubings. III. Kinetics and mechanism of thrombin, antithrombin III and thrombin-antithrombin complex adsorption under controlled-flow conditions.
    Migonney V; Fougnot C; Jozefowicz M
    Biomaterials; 1988 Sep; 9(5):413-8. PubMed ID: 3224126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy.
    Hogg PJ; Jackson CM
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3619-23. PubMed ID: 2726739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of heparin on thrombin inactivation by antithrombin-III.
    Machovich R; Arányi P
    Biochem J; 1978 Sep; 173(3):869-75. PubMed ID: 708377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of antithrombin III-independent thrombin inhibitors and heparin on fibrin accretion onto fibrin-coated polyethylene.
    Rubens FD; Weitz JI; Brash JL; Kinlough-Rathbone RL
    Thromb Haemost; 1993 Feb; 69(2):130-4. PubMed ID: 8456425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.